https://www.selleckchem.com/pr....oducts/lenalidomide-
Network abnormalities could help explain physical disability in multiple sclerosis (MS), which remains poorly understood. This study investigates functional network efficiency changes in the sensorimotor system. We included 222 MS patients, divided into low disability (LD, Expanded Disability Status Scale (EDSS) ⩽3.5, = 185) and high disability (HD, EDSS ⩾6, = 37), and 82 healthy controls (HC). Functional connectivity was assessed between 23 sensorimotor regions. Measures of efficiency were computed and compared between gro